BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 2595666)

  • 1. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
    McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
    Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ; Kabral A; Castaldi PA; Berndt MC
    Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H; McGregor JL
    Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
    Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
    Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a glycoprotein III a dimer in polyacrylamide gel separations of human platelet membranes.
    Calvete JJ; McGregor JL; Rivas G; González-Rodríguez J
    Thromb Haemost; 1987 Aug; 58(2):694-7. PubMed ID: 3672419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
    Caen JP; Rosa JP; Soria C; Boizard B
    C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa.
    Tanoue K; Hasegawa S; Yamaguchi A; Yamamoto N; Yamazaki H
    Thromb Res; 1987 Aug; 47(3):323-33. PubMed ID: 3629560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
    Lanza F; Stierlé A; Gachet C; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
    Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
    J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex--1. Glycoprotein analysis.
    Meyer M; Kirchmaier CM; Schirmer A; Spangenberg P; Ströhl C; Breddin K
    Thromb Haemost; 1991 May; 65(5):491-6. PubMed ID: 1871709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the deaggregation of human and rabbit platelets.
    Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
    Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a unique type of thrombopathy of human platelets: defect in the exposure of active fibrinogen receptors in a patient with Friedreich's ataxia.
    Kornecki E; Cooper BA; Ehrlich YH
    J Lab Clin Med; 1988 Jun; 111(6):618-26. PubMed ID: 2836536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
    Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
    Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.